Skip to content
10-Q

Quarterly Report

Rich Pharmaceuticals, Inc.

0001662252-18-000036

← back to feed
Filed
Feb 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Feb 19, 2018 1.22B sh
Operating Cash Flow Q3 2018 · Dec 31, 2017 −$369.65K
Operating Cash Flow Q3 2018 · Dec 31, 2016 −$288.93K
Short Term Debt Q3 2018 · Dec 31, 2017 $920K
Short Term Debt Q3 2018 · Mar 31, 2017 $920K
Cash And Equivalents Q3 2018 · Dec 31, 2017 $3.74K
Cash And Equivalents Q3 2018 · Mar 31, 2017 $40.9K
Stockholders Equity Q3 2018 · Dec 31, 2017 −$5.21M
Stockholders Equity Q3 2018 · Mar 31, 2017 −$5.33M
Current Liabilities Q3 2018 · Dec 31, 2017 $5.25M
Current Liabilities Q3 2018 · Mar 31, 2017 $5.38M
Total Liabilities Q3 2018 · Dec 31, 2017 $5.25M
Total Liabilities Q3 2018 · Mar 31, 2017 $5.38M
Current Assets Q3 2018 · Dec 31, 2017 $19.04K
Current Assets Q3 2018 · Mar 31, 2017 $50.9K
Total Assets Q3 2018 · Dec 31, 2017 $35.27K
Total Assets Q3 2018 · Mar 31, 2017 $53.03K
Rd Expense Q3 2018 · Dec 31, 2017 $92.75K
Rd Expense Q3 2018 · Dec 31, 2017 $241.16K
Net Income Q3 2018 · Dec 31, 2017 $55.35K
Net Income Q3 2018 · Dec 31, 2017 −$450.29K
Net Income Q3 2018 · Dec 31, 2016 −$540.45K
Net Income Q3 2018 · Dec 31, 2016 −$985.33K
Operating Income Q3 2018 · Dec 31, 2017 −$333.72K
Operating Income Q3 2018 · Dec 31, 2017 −$1.02M
Operating Income Q3 2018 · Dec 31, 2016 −$208.82K
Operating Income Q3 2018 · Dec 31, 2016 −$607.09K
Revenue Q3 2018 · Dec 31, 2017 $115K